
Pfizergate倿±ºãåããä¿å®ç³»æ¬§å·è°äŒè°å¡ããã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ã«å¯Ÿããæ¿æ²»ç責任ãèŠæ±
å èšäºã¯ãã¡ããã/Click here to read the original article.
欧å·åžæ³è£å€æïŒECJïŒã¯ã欧å·å§å¡äŒïŒECïŒå§å¡é·ãŠã«ãºã©ã»ãã©ã³ã»ãã¢ã»ã©ã€ãšã³ãããã¡ã€ã¶ãŒCEOã¢ã«ããŒãã»ããŒã©ãšã®COVID-19ã¯ã¯ãã³å¥çŽã«é¢ããç§å¯äº€æžã®ææžãäžæ³ã«éå ¬éãšããéææ§æ³ã«éåããŠãããšè£å®ããŸããã
欧å·å§å¡äŒã¯ãã®å€æ±ºãäžæãšããŠäžèšŽããå¯èœæ§ãé«ããææžã®å ¬éã¯ããã«1ïœ2幎é ããèŠéãã§ããè£å€æã¯æ¬§å·å§å¡äŒã®äž»åŒµããä»®å®ãŸãã¯äžæ£ç¢ºãªæ å ±ã«åºã¥ãããã®ããšããŠéããŸããã
ä¿å®ç³»ã®æ¬§å·è°äŒè°å¡ïŒMEPïŒã¯æ¿æ²»çè²¬ä»»ãæ±ãããã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ã®èŸä»»ãå«ã察å¿ãèŠæ±ããŠããŸãã圌女ã®éææ§ã®æ¬ åŠã¯éæ°äž»çã ãšéé£ãããã€ãŠãã€ãåœé²çžæä»£ã«ã責任åé¿ã®å§¿å¢ãèŠãããšææãããŠããŸãã
ECJã¯ãã®ä»¶ã§ãã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºçŽã®èšŽããèªããäžæ¹ã§ãäžè¬åžæ°ãNGOã«ããå¥ã®èšŽèšã¯åŽäžãæ å ±ãžã®å¹³çãªã¢ã¯ã»ã¹ãèªããããªãã£ãããšã«å¯Ÿããæãã®å£°ãäžãã£ãŠããŸãã
ãã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ã®åŽè¿ãæ¯æå¢åã圌女ããã°ãå¯èœæ§ãé«ãäžãä¿å®ç³»MEPãã¯å¬åæš©ãæã€è°äŒèª¿æ»ã®éå§ãæ±ããŠããŸããããããæ³çæç¶ãã®é ãã«ããå®å šãªéææ§ã¯åŠšããããæããããããPfizergateïŒãã¡ã€ã¶ãŒã²ãŒãïŒãã¯åœŒå¥³ã®æ¿æš©ã象城ããã¹ãã£ã³ãã«ãšãªããããããŸããã
欧å·è°äŒã®ä¿å®ç³»è°å¡ïŒMEPïŒãã¯ãããã¡ã€ã¶ãŒã²ãŒããã¹ãã£ã³ãã«ã«é¢é£ããæ¬§å·åžæ³è£å€æïŒECJïŒã®å€æ±ºãåããŠã欧å·å§å¡äŒïŒECïŒå§å¡é·ãŠã«ãºã©ã»ãã©ã³ã»ãã¢ã»ã©ã€ãšã³ã«å¯Ÿããæ¿æ²»çè²¬ä»»ãæ±ããŠããŸãã
ECJã¯2025幎5æ14æ¥ïŒæ°ŽïŒã«å€æ±ºãäžãããã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ããã¡ã€ã¶ãŒCEOã¢ã«ããŒãã»ããŒã©ãšã®ç§å¯äº€æžã«é¢ããéèŠææžãäžæ³ã«éå ¬éãšããæ°ååãã«èŠæš¡ã®COVID-19ïŒæŠæŒ¢ã³ãããŠã€ã«ã¹ïŒã¯ã¯ãã³å¥çŽã«é¢ããæ å ±ãé瀺ããªãã£ããšèªå®ããŸãããè£å€æã¯ãECå§å¡é·ãéææ§æ³ã«éåãããšããŠãææžã®éå ¬éæ±ºå®ãç¡å¹ãšããŸããã
è£å€æã¯ã欧å·å§å¡äŒã®äž»åŒµããä»®å®ãäžæ£ç¢ºãªæ å ±ã«åºã¥ããŠããããšããŠéããææžã®å³æé瀺ãåœããŸããããã ãããã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ãäžèšŽããèŠéãã§ãé瀺ã¯1ã2幎å éããããå¯èœæ§ããããŸãã
ãã®å€æ±ºã¯å®è³ªçãªå¹åãä¹ãããšèŠãããŠãããäž»æµã¡ãã£ã¢ã§ãããçŸå®çãªæ¿æ²»ç圱é¿ã¯ãªãããšèªããŠããŸãããšããã®ãããã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ãçŽæ¥çã«è²¬ä»»è¿œåã§ããä»çµã¿ããªããåœŒå¥³ãæ¯ããããŠã«ãºã©é£åããšåŒã°ããæ¬§å·è°äŒå
ã®å¢åã«ã責任远åã®æå¿ãèŠãããªãããã§ãã
ïŒé¢é£èšäºïŒãã¡ã€ã¶ãŒã²ãŒã â ãã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ã®äžéæãªCOVIDã¯ã¯ãã³å¥çŽã¯ã圌女ãâäœã§ãä¹ãåããâããšã蚌æãããïŒ
ãããä¿å®ç³»MEPãã¯ããã«å±ããããECJ倿±ºã«ããå ¬çãªå±èŸ±ããçŸå®ã®æ¿æ²»ççµæã«çµã³ã€ããã¹ãã ããšäž»åŒµãããã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ã®èŸä»»ãæ±ããŠããŸãã
ãã³ããŒã¯ã®MEPã§ããšãŒãããã®æåœè ãè°å¡ã°ã«ãŒãã«æå±ããã¢ã³ããŒã¹ã»ãŽã£ã¹ãã£ã»ã³æ°ã¯ããé ãããšããªããã°ãæããããšããªãã¯ãã ããšèªããŸããã
ãŸãããã©ã³ã¹ã®å MEPã§ãåœæ°é£åãæå±ã®ãããªã·ã¢ã»ã·ã£ãã§ã³æ°ãåæ§ã®èŠè§£ã瀺ãããæ¿æ²»å®¶ã¯ææš©è ããå§ä»»ãåããŠãã以äžã圌ãã«å¯ŸããŠè²¬ä»»ãè² ããªããã°ãªããªããäœããé ãå§ããæç¹ã§ãããã¯ãã¯ãæ°äž»äž»çŸ©ã§ã¯ãªãããšè¿°ã¹ãŸããã
欧å·è°äŒã¯ã€ãã«ãã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ã«è²¬ä»»ãåãã®ãïŒ
欧å·åžæ³è£å€æïŒECJïŒã®å€æ±ºã¯ãããã¡ã€ã¶ãŒã²ãŒããã¹ãã£ã³ãã«ã®äžã§é倧ãªè»¢æç¹ã瀺ããŠãããEUã®æé«æš©åå±€ã«ãããäœç³»çãªç§å¯äž»çŸ©ãé²åããŸããããã®åé¡ã«ã€ããŠäžéšã®è°å¡ã¯ãã人é¡å²äžæå€§ã®æ±è·ã¹ãã£ã³ãã«ããšåŒã³ãæ¥éãªèª¬æè²¬ä»»ã®å¿ èŠæ§ã蚎ããŠããŸãã
æ¹å€è ãã¡ã¯ããã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ã®è¡åãéå»ã®ã¹ãã£ã³ãã«ãšé¡äŒŒããŠãããšææããŠããŸãããã³ããŒã¯ã®æ¬§å·è°äŒè°å¡ïŒMEPïŒã¢ã³ããŒã¹ã»ãŽã£ã¹ãã£ã»ã³æ°ã¯ã圌女ããã€ãŠãã€ãã®é²è¡èª¿éãå·¡ãäžæ£äºä»¶ã§èšŒæ ãåé€ãããšãããéå»ãæã¡åºããŸããããã®ä»¶ã§ã圌女ã¯èª¬æè²¬ä»»ãå ãã2019å¹Žã«æ¬§å·å§å¡äŒå§å¡é·ã«å°±ä»»ããŠããŸãã
ä»åã®å€æ±ºã§ã¯ãæãããªäºéåºæºãæµ®ã圫ãã«ãªããŸãããæ¬§å·åžæ³è£å€æã¯ã**ãã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºïŒNYTïŒ**ãèµ·ããã蚎èšã«å¯ŸããŠã¯ææžé瀺ãèªããäžæ¹ã§ããã«ã®ãŒã§ã¯åžæ°ãNGOãå çåœãå«ã1,000人以äžãèµ·ãããå¥ã®èšŽèšãããåå¥çãªè¢«å®³ããªãããšããŠåŽäžãããŸããã
ãã€ãã®MEPã¯ãªã¹ãã£ãŒãã»ã¢ã³ããŒãœã³æ°ïŒã䞻暩åœå®¶ã®ããã®æ¬§å·ãäŒæŽŸïŒã¯ãã®äžå ¬å¹³ãå³ããæ¹å€ããXïŒæ§TwitterïŒã§ããªããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºããè°å¡ãåžæ°ãåŠå®ãããæš©å©ãåã¡åãããšãã§ããã®ãããšçåãåããŸããã
ãŸããå
ãªã©ã³ãMEPã§ã欧å·ä¿å®æ¹é©ã°ã«ãŒããæå±ã®ããã»ããŒã¹æ°ãXã§æ¬¡ã®ããã«è¿°ã¹ãŸããïŒ
ããªãå€åœã¡ãã£ã¢ããæ¬§å·è°å¡ã欧å·åžæ°ãå çåœããã匷ãéææ§ã®æš©å©ãæã£ãŠããã®ãïŒã
ãã©ã³ã»ãã¢ã»ã©ã€ãšã³æ°ã®åŽè¿ãæ¯æå¢åããããªã調æ»ã黿¢ããå¯èœæ§ãé«ãäžãæŠãã®èå°ã¯æ¬§å·è°äŒãžãšç§»ã£ãŠããŸããã¢ã³ããŒãœã³æ°ããŽã£ã¹ãã£ã»ã³æ°ãä¿å®ç³»è°å¡ã¯ãå¬åæš©ãæã€èª¿æ»å§å¡äŒã®èšçœ®ãåŒ·ãæ±ããŠããŸãã
ããããæ³çãªäºããé·åŒãäžã§ãçå®ã®å šè²ãæããã«ãªãæ¥ã¯æ¥ãªããããããŸããããã¡ã€ã¶ãŒã²ãŒãã¯ããã©ã³ã»ãã¢ã»ã©ã€ãšã³æ¿æš©ã象城ããã¹ãã£ã³ãã«ãšãªããæš©åã«å¯Ÿãããã§ãã¯æ©èœãåããªãããšã®èŠéãšããŠèšæ¶ãããå¯èœæ§ããããŸãã